Search Results 251-260 of 17138 for egfr

1. Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study - Mayo Clinic

   Severe renal dysfunction (eGFR< 30 ml/min/1.73m2); Requirement for inotropes (other than digoxin) or mechanical support during hospitalization; Clinically ...

2. A Study Of Intravesical BCG In Combination With ALT-803 In Patients With Non-Muscle Invasive Bladder Cancer - Mayo Clinic

   using the following Cockcroft-Gault equation to calculate the eGFR for this study: eGFR in mL/min = {(140-age in years) x (weight in kg) x F}/(serum creatinine ...

3. Phase 2a Study Of VX-407 In Participants With ADPKD Who Have A Subset Of PKD1 Gene Variants (AGLOW) - Mayo Clinic

   * Estimated glomerular filtration rate (eGFR) greater than or equal to (≥) 25 milliliter per minute (mL/min)/1.73 square meter (m\^2) Key Exclusion ...

4. Primary Sclerosing Cholangitis (PSC) Clinical Trials - Mayo Clinic Research

   Erlotinib (Tarceva) is a human EGFR type 1 tyrosine kinase inhibitor and offers greater survival benefit to EGFR positive patients. This study will assist ...

5. HEART: Pilot RCT - Mayo Clinic

   eGFR ≥ 50 mL/min/1.73 m²;. serum potassium ≤ 5.1 mmol/L;. ability to provide informed consent. Exclusion Criteria: Heritable aortopathies (Marfan, Loeys ...

6. A Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension Patients - Mayo Clinic

   The patient has severe renal impairment (eGFR < 35). The patient is taking inhaled treprostinil doses of greater than 90 μg (more than 15 breaths) ...

7. A Study to Evaluate Regorafenib with Cetuximab or Panitumumab to Treat Unresectable, Locally Advanced, or Metastatic Colorectal Cancer - Mayo Clinic

   The purpose of this study is to determine how well regorafenib and anti-EGFR therapy (cetuximab or panitumumab) works for the treatment of patients with ...

8. ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System - Mayo Clinic

   ... (eGFR) \< 25ml/min/1.73 m2 by CKD-Epi equation; or currently requiring dialysis * Performance of the six-minute walk test (6MWT) with a distance \< 50m OR ...

9. Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants with Chronic Cough - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m2 at Screening OR eGFR ≥30 mL/min/1.73 m2 and <50 mL/min/1.73 m2 at Screening with unstable ...

10. Rilonacept in Subjects with Cardiac Sarcoidosis - Mayo Clinic

    Estimated glomerular filtration rate (eGFR) (eGFR) \<30mL/min 19. Major surgery within 8 weeks prior to screening or planned major surgery within 6 months ...